Cargando…
642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients
BACKGROUNDS: Prevention of serious HIV-1-associated pneumococcal infections may be compromised by the limited magnitude and function of vaccine-induced antibodies. Responses to the T-independent pneumococcal capsular polysaccharide (PPS) + T-dependent diphtheria toxoid (DT) protein conjugate vaccine...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253450/ http://dx.doi.org/10.1093/ofid/ofy210.649 |
_version_ | 1783373497470287872 |
---|---|
author | Nicholson, Lindsay K Jha, Vibha Gardner, Edward M Rahkola, Jeremy Burton, Robert L Nahm, Moon H Janoff, Edward N |
author_facet | Nicholson, Lindsay K Jha, Vibha Gardner, Edward M Rahkola, Jeremy Burton, Robert L Nahm, Moon H Janoff, Edward N |
author_sort | Nicholson, Lindsay K |
collection | PubMed |
description | BACKGROUNDS: Prevention of serious HIV-1-associated pneumococcal infections may be compromised by the limited magnitude and function of vaccine-induced antibodies. Responses to the T-independent pneumococcal capsular polysaccharide (PPS) + T-dependent diphtheria toxoid (DT) protein conjugate vaccine (PCV-13) may be influenced by CD4+ T follicular helper (TFH) cells which provide specific help for B-cell differentiation. METHODS: We immunized 22 control and 19 newly diagnosed HIV-1-infected adults (median 610 CD4+ T cells/µL (range: 139–1,408) and 69,316 plasma HIV RNA (range 232-806,936) on ART for 1–4 months with PCV13. We measured (i) PPS-specific antibody-secreting cells (ASC) by ELISPOT at Weeks 0 and 1, (ii) serum IgG to 11 PPS serotypes (ST) by multiplex ELISA and (iii) titers of opsonophagocytosis (OP) for four STs at Weeks 0 and 8, and (iv) numbers and activation (ICOS expression) of circulating TFH cells by flow cytometry at Weeks 0 and 1. Values were compared by ANOVA, paired and unpaired t and Mann–Whitney tests. RESULTS: The number of PPS-specific IgG, IgM and IgA ASC increased significantly from Weeks 0 to 1 post-PCV13 and to similar magnitude in both Controls and HIV+ subjects, returning to baseline by Week 8. Levels of serum PPS-specific IgG increased significantly from Weeks 0 to 8 for 10/11 vs. 7/11 ST in controls and HIV+ subjects, respectively (P = NS), and to comparable levels. Similarly, OP titers increased significantly and similarly to each of four STs in both groups from Weeks 0 to 8. In contrast, although DT-specific IgG ASC increased from Weeks 0 to 1 in HIV+ and controls, these values were lower among HIV-1+ adults (P = .001). Consistent with these limited responses, a key regulatory molecule on TFH cells, elicited largely by T-dependent antigens (DT), was upregulated on cells from Control but not HIV+ at Week 1. Moreover, levels of IL-12, which drives TFH differentiation, were also lower among HIV-1+ at Week 1. Conclusion. Humoral responses to PPS are largely intact (ASC, serum IgG and killing function) with recently diagnosed HIV-1 infection, highlighting the importance of early HIV-1 recognition. That responses to T-dependent DT and TFH activation are more limited, even with high CD4+ counts and ART, suggests a more rapid and perhaps more recalcitrant HIV-1-associated T-cell defect. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6253450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62534502018-11-28 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients Nicholson, Lindsay K Jha, Vibha Gardner, Edward M Rahkola, Jeremy Burton, Robert L Nahm, Moon H Janoff, Edward N Open Forum Infect Dis Abstracts BACKGROUNDS: Prevention of serious HIV-1-associated pneumococcal infections may be compromised by the limited magnitude and function of vaccine-induced antibodies. Responses to the T-independent pneumococcal capsular polysaccharide (PPS) + T-dependent diphtheria toxoid (DT) protein conjugate vaccine (PCV-13) may be influenced by CD4+ T follicular helper (TFH) cells which provide specific help for B-cell differentiation. METHODS: We immunized 22 control and 19 newly diagnosed HIV-1-infected adults (median 610 CD4+ T cells/µL (range: 139–1,408) and 69,316 plasma HIV RNA (range 232-806,936) on ART for 1–4 months with PCV13. We measured (i) PPS-specific antibody-secreting cells (ASC) by ELISPOT at Weeks 0 and 1, (ii) serum IgG to 11 PPS serotypes (ST) by multiplex ELISA and (iii) titers of opsonophagocytosis (OP) for four STs at Weeks 0 and 8, and (iv) numbers and activation (ICOS expression) of circulating TFH cells by flow cytometry at Weeks 0 and 1. Values were compared by ANOVA, paired and unpaired t and Mann–Whitney tests. RESULTS: The number of PPS-specific IgG, IgM and IgA ASC increased significantly from Weeks 0 to 1 post-PCV13 and to similar magnitude in both Controls and HIV+ subjects, returning to baseline by Week 8. Levels of serum PPS-specific IgG increased significantly from Weeks 0 to 8 for 10/11 vs. 7/11 ST in controls and HIV+ subjects, respectively (P = NS), and to comparable levels. Similarly, OP titers increased significantly and similarly to each of four STs in both groups from Weeks 0 to 8. In contrast, although DT-specific IgG ASC increased from Weeks 0 to 1 in HIV+ and controls, these values were lower among HIV-1+ adults (P = .001). Consistent with these limited responses, a key regulatory molecule on TFH cells, elicited largely by T-dependent antigens (DT), was upregulated on cells from Control but not HIV+ at Week 1. Moreover, levels of IL-12, which drives TFH differentiation, were also lower among HIV-1+ at Week 1. Conclusion. Humoral responses to PPS are largely intact (ASC, serum IgG and killing function) with recently diagnosed HIV-1 infection, highlighting the importance of early HIV-1 recognition. That responses to T-dependent DT and TFH activation are more limited, even with high CD4+ counts and ART, suggests a more rapid and perhaps more recalcitrant HIV-1-associated T-cell defect. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253450/ http://dx.doi.org/10.1093/ofid/ofy210.649 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Nicholson, Lindsay K Jha, Vibha Gardner, Edward M Rahkola, Jeremy Burton, Robert L Nahm, Moon H Janoff, Edward N 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title | 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title_full | 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title_fullStr | 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title_full_unstemmed | 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title_short | 642. B- and T-Cell Responses to Pneumococcal Polysaccharide and Protein Vaccine Antigens in Recently Diagnosed HIV-1-Infected Patients |
title_sort | 642. b- and t-cell responses to pneumococcal polysaccharide and protein vaccine antigens in recently diagnosed hiv-1-infected patients |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253450/ http://dx.doi.org/10.1093/ofid/ofy210.649 |
work_keys_str_mv | AT nicholsonlindsayk 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT jhavibha 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT gardneredwardm 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT rahkolajeremy 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT burtonrobertl 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT nahmmoonh 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients AT janoffedwardn 642bandtcellresponsestopneumococcalpolysaccharideandproteinvaccineantigensinrecentlydiagnosedhiv1infectedpatients |